Status: Recruiting
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
The purpose of this study is to test which treatment schedule of β-glucan with bivalent vaccine is more effective for participants with high-risk neuroblastoma that is in complete remission.
Participants needed: 94
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Jun 5, 2026Locations: 7
Eligibility criteria
Diagnosis of NB as defined by international criteria,102 i.e., histopathology (c... [+7]
Patients with grade 4 hematologic, cardiac, neurological, pulmonary, renal, hepa... [+4]